WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease

Camille Cohen,Rana Mhaidly,Hugo Croizer,Yann Kieffer,Renaud Leclere,Anne Vincent-Salomon,Catherine Robley,Dany Anglicheau,Marion Rabant,Aurélie Sannier,Marc-Olivier Timsit,Sean Eddy,Matthias Kretzler,Wenjun Ju,Fatima Mechta-Grigoriou
DOI: https://doi.org/10.1038/s41467-024-44886-z
IF: 16.6
2024-01-25
Nature Communications
Abstract:Abstract Chronic kidney disease (CKD) is a public health problem driven by myofibroblast accumulation, leading to interstitial fibrosis. Heterogeneity is a recently recognized characteristic in kidney fibroblasts in CKD, but the role of different populations is still unclear. Here, we characterize a proinflammatory fibroblast population (named CXCL-iFibro), which corresponds to an early state of myofibroblast differentiation in CKD. We demonstrate that CXCL-iFibro co-localize with macrophages in the kidney and participate in their attraction, accumulation, and switch into FOLR2+ macrophages from early CKD stages on. In vitro, macrophages promote the switch of CXCL-iFibro into ECM-secreting myofibroblasts through a WNT/β-catenin-dependent pathway, thereby suggesting a reciprocal crosstalk between these populations of fibroblasts and macrophages. Finally, the detection of CXCL-iFibro at early stages of CKD is predictive of poor patient prognosis, which shows that the CXCL-iFibro population is an early player in CKD progression and demonstrates the clinical relevance of our findings.
multidisciplinary sciences
What problem does this paper attempt to address?